Mislabeling Alert: Cough Suppressant Recalled Due to Presence of Oral Anesthetic
Novis PR LLC has initiated a recall for a particular batch of G-Supress DX Pediatric Drops Cough Suppressant Nasal Decongestant Cherry Flavor due to incorrect product inclusion within the carton packaging.
There have been instances reported where the product inside the packages, labeled as the cough suppressant, was found to be Finafta Anesthetic/Analgesic Liquid. This product, which is not produced by Novis, is used for temporary relief from mouth irritations and inflammations and contains 60% ethyl alcohol and 5% benzocaine. The Finafta Anesthetic/Analgesic Liquid is usually provided in 15mL bottles.
Children consuming Finafta face a heightened risk of experiencing severe adverse consequences such as alcohol toxicity, hypoglycemia, a comatose state, hypothermia, or even death.
Benzocaine consumption also poses considerable safety hazards, including a potential case of methemoglobinemia.
The FDA is issuing an advisory against the purchase of Lot# D20911 of G-Supress DX Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant Cherry Flavor with an expiration date of 10/25. This product has only been distributed within Puerto Rico.
There have been no adverse events related to this recall reported at present. Customers can reach out to Novis for any queries. Any adverse events should be reported to the FDA’s MedWatch program.
Taking Legal Action for Harm Caused by a Product
In the event that a product, such as the G-Supress DX Pediatric Drops, causes harm, there may be grounds for a lawsuit to seek monetary compensation for damages incurred. This legal recourse falls under product liability law, a field that holds manufacturers, distributors, retailers, and suppliers accountable for providing defective or harmful products to consumers.
The first step in launching such a lawsuit is consulting with a product liability attorney. These legal professionals can guide you through the complex legal terrain and assess the validity of your case, based on the seriousness of the injury, your personal losses, and the causative link between the product and your injury. Key to supporting your claim will be evidence of injury resulting from the product, often in the form of medical records or documents.
In the context of the Novis recall case, potential plaintiffs would need to demonstrate that the incorrectly labeled product led to their injury. This could be significant, given that the ingestion of a product containing alcohol and benzocaine, like the Finafta Anesthetic/Analgesic Liquid, can result in serious health issues in children.
Successful lawsuits can result in compensation that covers medical expenses, lost wages due to inability to work, and non-economic damages such as pain and suffering. In some instances, punitive damages may be awarded to penalize the defendant and deter similar conduct in the future.
However, filing a product liability lawsuit can be a complex process. The criteria for a defective product can vary by jurisdiction, and establishing a direct link between the product and the injury can be challenging. Hence, it is essential to seek legal counsel experienced in product liability law.
Furthermore, such legal actions can also potentially lead to improved product safety regulations and measures, thereby preventing similar harm to others in the future. In this way, these lawsuits can not only provide compensation but also contribute to improving product safety standards overall. Therefore, if you or a loved one has been affected by a defective product, promptly seeking legal advice is crucial.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
Were you or a loved one harmed by a recalled product? Parker Waichman LLP helps families recover monetary compensation for harm caused by dangerous products. For your free consultation, contact our national product liability law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).